Roche's surging diagnostics arm scored a major win this week, gaining FDA approval what is being billed as the first companion diagnostic meant to detect a specific mutation connected to metastatic non-small cell lung cancer.
Roche's diagnostics division generated mixed results in its 2013 first quarter. The Swiss drug giant generally enjoyed increased sales for its patient and laboratory tests. But the company's diabetes division continued to struggle, hammered by reimbursement cuts and tougher pricing pressures.
GE Healthcare has been steadily building up its diagnostics offerings over the past three years, and now the company is launching a sequencing assay targeting solid tumors in clinical trials.
PrimeraDx, a 2012 Fierce 15 company, has hitched on with Quest Diagnostics to co-develop companion diagnostics, giving the company a major megaphone to attract Big Pharma deals.
Sundance Diagnostics is pursuing a novel path for companion diagnostics development--blood tests that will gauge a patient's risk for suicide while taking certain antidepressant drugs. The new twist: The blood tests will be paired with prescription drugs already on the market.
Merck is pressing forward with its controversial Alzheimer's treatment, and now it has signed a deal with Luminex to develop a companion diagnostic that will screen patients for its ongoing clinical program.
Dako has been on a tear with big-name companion diagnostics partnerships, and its latest one might end up being the most lucrative: The company has received FDA approval for two tests to be paired with Kadcyla, Roche's soon-to-explode breast cancer drug.
Johnson & Johnson scored a major victory with the FDA this month when the agency put its breakthrough designation on an investigational cancer drug, and now Abbott Laboratories is stepping in to develop a companion diagnostic for the headline-grabbing compound.
Eli Lilly is expanding its partnership with Qiagen, building off of past success in a new broad collaboration agreement for companion diagnostics.
Agilent Techologies' Dako unit has added Pfizer to its list of companion diagnostics partners, signing a deal that covers the research, development and commercialization of tests to match the drugmaker's pipeline treatments.